PRN Physician Recommended Nutriceuticals Announces the Launch of an International Scientific Advisory Board

Feb 12, 2013, 10:00 ET from PRN Physician Recommended Nutriceuticals

PLYMOUTH MEETING, Pa., Feb. 12, 2013 /PRNewswire/ -- PRN Physician Recommended Nutriceuticals, a premier producer of condition-specific omega-3 products and macular vitamins, today announced the launch of its International Scientific Advisory Board (ISAB) comprising five of the world's most renowned thought leaders in ophthalmology.  The new ISAB will replace the former Medical Advisory Panel and will provide specific advice on research, education of the medical community on the value of PRN products, evaluation of new product offerings, and strategic guidance for PRN's Dry Eye Omega Benefits®, Eye Omega Advantage®, and Macular Vitamin Benefits, where applicable.

Members of PRN's ISAB will include Sheraz Daya, MD, Eric Donnenfeld, MD, Allen Ho, MD, Richard Lindstrom, MD, and Frank Bucci, MD. On joining the ISAB, Dr. Donnenfeld commented, "I always support and attempt to contribute to improving patient care through advanced technology products.  I strongly believe that PRN's contribution to the future of ophthalmology is historic, and I am thrilled to be a part of PRN's success." Echoing those sentiments, Dr. Lindstrom added, "Appropriate nutriceutical therapy has helped many of my patients, and I am inspired to offer guidance and support to PRN as they rapidly expand the number of patients using their omega-3 and macular vitamin products.  Together, I believe, we are making a significant advance in the treatment of many eye diseases."

The five members of the ISAB will offer diverse backgrounds and expertise.  Dr. Daya is Founder and Medical Director of the internationally recognized Centre for Sight located in the UK.  He is an expert in stem cell transplantation, tissue engineering, corneal procedures, LASIK and other refractive surgery techniques, and has also invented a series of innovative ophthalmic instruments for use in corneal transplantation, collagen cross linking (CXL), laser refractive surgery and more recently femtosecond laser cataract surgery.  Dr. Donnenfeld joins the ISAB from Ophthalmic Consultants of Long Island (OCLI) as a clinical professor of ophthalmology at New York University and a trustee of Dartmouth Medical School.  A well respected innovator he has authored more than 180 papers on cornea, external disease, cataract and refractive surgery, 500 scientific articles, and 20 books and book chapters on a range of subjects pertaining to corneal transplantation, refractive cataract surgery and laser vision correction.  Dr. Ho is Attending Surgeon for the Wills Eye Retina Service in Philadelphia and a professor of ophthalmology at Thomas Jefferson University.  He has been named on the list of "Best Doctors in America", Castle Connolly's Ltd. "America's Top Ophthalmologists" and "Top Doctors of Philadelphia" as elected by peer physicians. Dr. Lindstrom, founder and Attending Surgeon of Minnesota Eye Consultants and Adjunct Professor Emeritus at the University of Minnesota Department of Ophthalmology, is a leader in corneal, cataract, refractive and laser surgery. He has been at the forefront of ophthalmology's evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.  Dr. Bucci is an expert in refractive and cataract surgery. He has been a pioneer in refractive surgery, having performed some of the first RK, AK, PRK and LASIK procedures in the Northeast United States.

The commitment of these five prominent medical advisors is a testament to PRN's impact on present and future medical practice in ophthalmology.  PRN's Chief Medical Officer, Michael B. Gross, MD, PhD, noted, "The cornerstone of PRN has always been the scientific research and medical endorsement of the world's leading doctors.  The expertise and foresight in this group of thought leaders is unparalleled in ophthalmology, and we are confident that the new ISAB will provide PRN with unprecedented intellectual power as the company continues to rapidly grow.  Furthermore, this group of world-renowned ophthalmic thought leaders endorses the use of omega–3 clinical nutrition in the proper dose and form, as an adjunctive therapy to other ophthalmic approaches."

About PRN Physician Recommended Nutriceuticals

PRN is a leading developer of condition-specific omega-3 products and nutritional supplements.  Developed by doctors and recommended by world-renowned medical thought leaders, PRN's products are supported by medical evidence and offer exceptional quality and purity. Recently acknowledged on the Inc. 500|5000 list of fastest growing privately held companies, PRN has demonstrated three-year revenue growth of 375%.


SOURCE PRN Physician Recommended Nutriceuticals